Psychiatry · Midlothian, VA
NPI
1689653107
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
13354 Midlothian Tpke, Suite 100
Midlothian, VA, 23113
Phone (804) 794-2444
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
3,552 services
Medicare patients, 2024
362
Average age 53
Drug cost, 2024
$534K
10,960 prescriptions
Company payments, 2025
$1,247
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam T Kaul was code 99214 (office e&m - established), 1,483 times for 340 patients. In total Adam T Kaul billed 3,552 services in 12 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,483 | 340 | $73.83 | $109K |
| 90833 Psychotherapy - Nongroup | Office | 1,002 | 271 | $49.36 | $49K |
| 90785 Behavioral Health Services | Office | 663 | 171 | $10.27 | $6,811 |
| 99215 Office E&M - Established | Office | 274 | 102 | $97.98 | $27K |
| 90836 Psychotherapy - Nongroup | Office | 44 | 43 | $56.88 | $2,503 |
| 96127 Behavioral Health Services | Office | 39 | 20 | $2.08 | $81.12 |
| 99205 Office E&M - New | Office | 31 | 31 | $101.67 | $3,152 |
By year: 2022 $201K for 3,209 services; 2023 $227K for 3,842 services; 2024 $199K for 3,552 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam T Kaul prescribed most often to Medicare patients was Risperidone, with 1,193 prescriptions and refills. In total Adam T Kaul wrote 10,960 Medicare prescriptions that cost $534K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Risperidone Generic | 1,193 | 1,301 | 96 | $21K |
| Benztropine Mesylate Generic | 785 | 807 | 80 | $12K |
| Quetiapine Fumarate Generic | 651 | 674 | 52 | $17K |
| Trazodone Hcl Generic | 598 | 644 | 60 | $13K |
| Escitalopram Oxalate Generic | 519 | 559 | 52 | $6,539 |
| Divalproex Sodium Er Divalproex Sodium | 512 | 518 | 47 | $48K |
| Olanzapine Generic | 435 | 449 | 29 | $11K |
| Clonidine Hcl Generic | 433 | 470 | 44 | $4,197 |
| Clonazepam Generic | 432 | 435 | 41 | $4,812 |
| Topiramate Generic | 417 | 436 | 41 | $8,943 |
| Divalproex Sodium Generic | 340 | 344 | 31 | $13K |
| Aripiprazole Generic | 323 | 375 | 27 | $63K |
| Lorazepam Generic | 236 | 238 | 36 | $2,706 |
| Oxcarbazepine Generic | 232 | 251 | 23 | $17K |
| Sertraline Hcl Generic | 207 | 219 | 19 | $2,132 |
Brand drugs: 203 claims; generic drugs: 10,742 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam T Kaul $1,247 ($1,247 in general payments such as food, travel and fees) from 9 companies. The largest payer was Neurocrine BioSciences, Inc. with $515.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 20 | $515 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $262 |
| Vanda Pharmaceuticals Inc. VNDA | 9 | $158 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $75.4 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $68.52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $55.78 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $46.93 |
| Abbvie Inc. ABBV | 2 | $43.15 |
| Lundbeck LLC | 1 | $21.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.